Healthcare provider profile · identity verified

Raquel D Danko, ANP

Nurse Practitioner · LITTLE ROCK, AR · NPI 1821196445

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	557	136
Omeprazole	Omeprazole	406	97
Lisinopril	Lisinopril	376	83
Losartan Potassium	Losartan Potassium	372	86
Levothyroxine Sodium	Levothyroxine Sodium	340	81
Rosuvastatin Calcium	Rosuvastatin Calcium	337	84
Amlodipine Besylate	Amlodipine Besylate	307	75
Gabapentin	Gabapentin	230	65
Hydrochlorothiazide	Hydrochlorothiazide	224	52
Trazodone Hcl	Trazodone Hcl	191	45
Metformin Hcl Er	Metformin Hcl	189	40
Pantoprazole Sodium	Pantoprazole Sodium	185	48
Metformin Hcl	Metformin Hcl	184	41
Sertraline Hcl	Sertraline Hcl	158	41
Metoprolol Succinate	Metoprolol Succinate	141	39
Tamsulosin Hcl	Tamsulosin Hcl	140	30
Albuterol Sulfate Hfa	Albuterol Sulfate	137	49
Duloxetine Hcl	Duloxetine Hcl	137	31
Potassium Chloride	Potassium Chloride	126	34
Metoprolol Tartrate	Metoprolol Tartrate	123	27
Simvastatin	Simvastatin	120	31
Glipizide	Glipizide	111	32
Pravastatin Sodium	Pravastatin Sodium	108	29
Fluticasone Propionate	Fluticasone Propionate	107	48
Meloxicam	Meloxicam	103	32
Furosemide	Furosemide	94	27
Ondansetron Odt	Ondansetron	86	20
Allopurinol	Allopurinol	78	21
Cefdinir	Cefdinir	78	66
Atenolol	Atenolol	76	18
Citalopram Hbr	Citalopram Hydrobromide	76	16
Tizanidine Hcl	Tizanidine Hcl	76	26
Carvedilol	Carvedilol	73	17
Clopidogrel	Clopidogrel Bisulfate	69	15
Ezetimibe	Ezetimibe	68	15
Januvia	Sitagliptin Phosphate	68	suppressed
Trulicity	Dulaglutide	67	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	64	11
Azithromycin	Azithromycin	61	53
Bupropion Xl	Bupropion Hcl	61	12
Ozempic	Semaglutide	61	12
Prednisone	Prednisone	57	47
Alendronate Sodium	Alendronate Sodium	55	14
Aripiprazole	Aripiprazole	52	12
Diclofenac Sodium	Diclofenac Sodium	52	18
Donepezil Hcl	Donepezil Hcl	52	11
Oxybutynin Chloride Er	Oxybutynin Chloride	52	13
Levetiracetam	Levetiracetam	51	suppressed
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Jardiance	Empagliflozin	50	11
Breo Ellipta	Fluticasone/Vilanterol	49	suppressed
Alprazolam	Alprazolam	48	suppressed
Clonazepam	Clonazepam	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	13
Baclofen	Baclofen	45	suppressed
Montelukast Sodium	Montelukast Sodium	44	12
Eliquis	Apixaban	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Buspirone Hcl	Buspirone Hcl	41	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	37
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Cephalexin	Cephalexin	37	28
Doxycycline Monohydrate	Doxycycline Monohydrate	37	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Mirtazapine	Mirtazapine	37	11
Valsartan	Valsartan	37	suppressed
Spironolactone	Spironolactone	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	34	15
Celecoxib	Celecoxib	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	31
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	21
Temazepam	Temazepam	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	11
Synthroid	Levothyroxine Sodium	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	14
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Famotidine	Famotidine	29	12
Klor-Con 10	Potassium Chloride	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Fluconazole	Fluconazole	27	20
Finasteride	Finasteride	26	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Mupirocin	Mupirocin	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Colchicine	Colchicine	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Belsomra	Suvorexant	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Ibu	Ibuprofen	13	suppressed
Nystatin	Nystatin	13	11
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Sucralfate	Sucralfate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error